Most Genetic Epidemiology Branch investigations evaluate the contributions of host susceptibility and environmental exposure in the development of cancer. In family studies, the host susceptibility measure is frequently an alteration in specific gene(s). These studies tend to be very long term with varying activity. Although two genes associated with melanoma susceptibility have been identified (CDKN2A and CDK4), alterations in these genes are found in only a small percentage of melanoma-prone families. The search for other genes continues;in collaboration with an international consortium (GenoMEL), a search for new melanoma susceptibility genes continues both within families and genome-wide association studies. In the American and Italian melanoma-prone families, we are using novel technologies including array comparative genomic hybridization (aCGH) and next generation sequencing to search for new high-risk melanoma susceptibility genes. We continue to accrue and evaluate new families in both the U.S and Italy. We have continued to evaluate families of individuals with heritable retinoblastoma and melanoma. The study of familial chordoma, a rare, low-grade, malignant bone tumor derived from remnants of the notochord, was expanded to include additional families. Recently we used array CGH to determine that duplications of the T gene (brachyury), which is important in notocord development, and is expressed in most sporadic chordomas, co-segregated with chordoma in members of four multiplex chordoma families. This was the first example of gene duplication conferring major familial susceptibility to cancer. We are currently using exome sequencing to search for disease-causing mutations in chordoma families without T gene duplications. Studying families with lymphoproliferative cancers has been a long-standing interest. We have collaborated with the Genetic Epidemiology of CLL Consortium to conduct larger studies of familial CLL. We are using exomic and whole genome sequencing to search for high risk susceptibility genes in CLL , HD, WM, and NHL families. We also continued a family study of Xeroderma pigmentosum in collaboration with CCR investigators to assess risk of cancer in XP heterozygotes. Data collection is underway. Neurologic degeneration is a major cause of morbidity and mortality among XP patients, and varies by subgroup. We have also documented that mothers carrying affected children with tricothiodystrophy have more pregnancy complications than when carrying unaffected children.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIACP004410-36
Application #
8565410
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
36
Fiscal Year
2012
Total Cost
$3,963,083
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
Zip Code
Baker, Maria J; Goldstein, Alisa M; Gordon, Patricia L et al. (2016) An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies. J Med Genet :
Castillo, Jorge J; Garcia-Sanz, Ramon; Hatjiharissi, Evdoxia et al. (2016) Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia. Br J Haematol 175:77-86
Shi, Jianxin; Zhou, Weiyin; Zhu, Bin et al. (2016) Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma. J Invest Dermatol 136:2436-2443
Goldin, Lynn R; McMaster, Mary L; Rotunno, Melissa et al. (2016) Whole exome sequencing in families with CLL detects a variant in Integrin ? 2 associated with disease susceptibility. Blood 128:2261-2263
Yang, Xiaohong R; Rotunno, Melissa; Xiao, Yanzi et al. (2016) Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations. Hum Genet 135:1241-1249
Rotunno, Melissa; Sun, Xuezheng; Figueroa, Jonine et al. (2014) Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res 16:R74
Shi, Jianxin; Yang, Xiaohong R; Ballew, Bari et al. (2014) Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet 46:482-6
Goldstein, Alisa M; Tucker, Margaret A (2013) Dysplastic nevi and melanoma. Cancer Epidemiol Biomarkers Prev 22:528-32
Goldin, Lynn R; McMaster, Mary L; Caporaso, Neil E (2013) Precursors to lymphoproliferative malignancies. Cancer Epidemiol Biomarkers Prev 22:533-9
Hill, Victoria K; Gartner, Jared J; Samuels, Yardena et al. (2013) The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet 14:257-79

Showing the most recent 10 out of 49 publications